Mashup Score:81
New England Journal of Medicine (NEJM)Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM - 1 month
Mashup Score:81
# ATS2022
Mashup Score:64
New England Journal of Medicine (NEJM)Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma | NEJM - 1 month
Mashup Score:64
Original Article from The New England Journal of Medicine — Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for...
-
The risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone. #ATS2022 https://t.co/MRGaUaGVwj https://t.co/MRGaUaGVwj - view on twitter
More coverage:
#ats2022
Mashup Score:21
PubMedProviding Compassionate Care in the ICU – PubMed - 1 month
Mashup Score:21
Providing Compassionate Care in the...
-
Don’t miss Dr. J. Randall Curtis @JRandallCurtis1 Tuesday, May 17, “Promoting compassion in clinical care, research, training, and mentoring” https://t.co/BNp6fv0j4m 11:30 a.m. Room 3000 (West Building, Level 3). https://t.co/BNp6fv0j4m #ATS2022 - view on twitter
More coverage:
#ats2022
Mashup Score:14
ATSConferenceNews.orgDr. Curtis Advocates for Palliative Care for All ICU Patients and Their Families – ATSConferenceNews.org - 1 month
Mashup Score:14
J. Randall Curtis, MD, MPH, a past ATS president, spoke about promoting compassion in clinical care, research, training, and mentoring at the Plenary Session....
-
At the #ATS2022 Plenary Session, @jrandallcurtis1 spoke about promoting compassion in clinical care, research, training, and mentorship. Read a recap in ATS Conference News: https://t.co/cplcyycOnd @LynnSchnappMD https://t.co/cplcyycOnd - view on twitter
More coverage:
#ats2022
Mashup Score:13
conference.thoracic.orgATS Conference 2022 – ATS 2022: On-Demand Highlights - 1 month
Mashup Score:13
American Thoracic...
-
In-person #ATS2022 may be over, but you can access some of the conference’s best content through our on-demand offering starting May 25. Learn more: https://t.co/BX2NCphHeA https://t.co/BX2NCphHeA - view on twitter
More coverage:
#ats2022
Mashup Score:13
conference.thoracic.orgATS Conference 2022 – ATS 2022: On-Demand Highlights - 1 month
Mashup Score:13
American Thoracic...
-
Not able to join us at #ATS2022? You can access some of the conference’s best content through our on-demand offering starting May 25. Learn more: https://t.co/BX2NCphHeA - view on twitter
More coverage:
#ats2022
Mashup Score:12
ATSConferenceNews.orgIssue 2 Archives – ATSConferenceNews.org - 1 month
Mashup Score:12
...
-
Don't miss the great sessions on the schedule Monday at #ATS2022! See what you can expect in ATS Conference News: https://t.co/eFMp11oMUY https://t.co/eFMp11oMUY - view on twitter
More coverage:
#ats2022
Mashup Score:12
ATSConferenceNews.orgOn-Demand Highlights Extend Access to Science, Industry at ATS 2022 – ATSConferenceNews.org - 4 weeks
Mashup Score:12
Available May 25-June 24 in a convenient virtual platform, the ATS 2022 On-Demand Highlights will showcase some of the best scientific content from the...
-
#ATS2022 On-Demand Highlights are available through June 24. Learn more in ATS Conference News, and catch up on sessions today: https://t.co/a1NOzIbO9E @AndrewHalayko https://t.co/a1NOzIbO9E - view on twitter
More coverage:
#ats2022
Mashup Score:11
MedscapeRace-Based Spirometry May Lead to Missed Diagnoses - 1 month
Mashup Score:11
Adjusting for purported racial differences may lead to underdiagnosis and undertreatment of Black...
-
It may be time to move beyond relying largely on spirometry to distinguish between healthy and abnormal lung function in diverse populations. https://t.co/qBn7ibkUva #ATS2022 https://t.co/qBn7ibkUva - view on twitter
More coverage:
#ats2022
Mashup Score:11
MedscapeRace-Based Spirometry May Lead to Missed Diagnoses - 1 month
Mashup Score:11
Adjusting for purported racial differences may lead to underdiagnosis and undertreatment of Black...
-
Work presented yesterday at #ATS2022, & some recent papers including one from colleagues and I, undercuts basis of race-based lung function equations. I have some comments on this in an article highlighting important research led by Dr. Gabrielle Liu https://t.co/bCW65pBeEj https://t.co/bCW65pBeEj - view on twitter
More coverage:
#ats2022
Original Article from The New England Journal of Medicine — Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary...
In a placebo-controlled trial, treatment with the phosphodiesterase 4 inhibitor BI 1015550 prevented a decrease in lung function over a 12-week period in patients with idiopathic pulmonary fibrosis. #ATS2022 https://t.co/G60NO2ntRR https://t.co/G60NO2ntRR - view on twitter